FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response...
0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      
1. Name and Address of Reporting Person * Nijhawan Pardeep 2. Issuer Name and Ticker or Trading Symbol Edesa Biotech, Inc. [ EDSA ] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable)__X__ Director                    __X__ 10% Owner
__X__ Officer (give title below)    _____ Other (specify below)
Chief Executive Officer
(Last)         (First)         (Middle)
C/O EDESA BIOTECH INC., 100 SPY COURT
3. Date of Earliest Transaction (MM/DD/YYYY)
5/26/2020
(Street)
MARKHAM, A6 L3R 5H6
(City)       (State)       (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)
 
6. Individual or Joint/Group Filing (Check Applicable Line) ___ Form filed by One Reporting Person
_ X _ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Shares  5/26/2020    P    3000  A $2.9797  2124024  I  Held by Pardeep Nijhawan Medicine Professional Corporation (1) (1)
Common Shares                 224094  I  Held by The Digestive Health Clinic Inc. (1) (1)
Common Shares                 537312  D   

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security 3. Trans. Date 3A. Deemed Execution Date, if any 4. Trans. Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
6. Date Exercisable and Expiration Date 7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares

Explanation of Responses:
(1)  Each of Pardeep Medicine Professional Corporation and The Digestive Health Clinic Inc. are wholly-owned by Pardeep Nijhawan.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
Nijhawan Pardeep
C/O EDESA BIOTECH INC.
100 SPY COURT
MARKHAM, A6 L3R 5H6
X X Chief Executive Officer
Pardeep Nijhawan Medicine Professional Corp
C/O EDESA BIOTECH INC.
100 SPY COURT
MARKHAM, A6 L3R5H6
X X Chief Executive Officer

Signatures
/s/ Pardeep Nijhawan 5/28/2020
**Signature of Reporting Person Date
/s/ Pardeep Nijhawan Medicine Professional Corporation, by Pardeep Nijhawan 5/28/2020
**Signature of Reporting Person Date
Edesa Biotech (NASDAQ:EDSA)
Historical Stock Chart
From Aug 2020 to Sep 2020 Click Here for more Edesa Biotech Charts.
Edesa Biotech (NASDAQ:EDSA)
Historical Stock Chart
From Sep 2019 to Sep 2020 Click Here for more Edesa Biotech Charts.